Research and Funding

Division of Extramural Activities

NIA Funding Policy for FY 2014

Update: December 2013

NIA, like other NIH Institutes, is funded under a continuing resolution (HR 2775, The Continuing Appropriations Act 2014) that provides funds in proportion to the sequestered 2013 budget, and ends on January 15. Substantial uncertainty remains about our budget for the remainder of the year after January 15. For this reason NIA, as in FY 2013, is making an initial conservative allocation of funds across most funding categories. We do expect to change this pay line after a full year budget has been announced and will then announce the anticipated pay line for the remainder of the year.

NIH separately issued a policy for noncompeting awards during this continuing resolution (CR). These awards are being made at up to 90% of their committed level during the CR. Similar to competing awards, we expect these levels to be adjusted when we have a full year budget.

Update: March 2014

NIH received a full year appropriation on January 14, 2014. The approximately 3% increase to $30.15 billion restores about $1 billion of the sequestration loss in FY 2013. On that basis NIA has now determined that we will pay research grant applications to at least the pay lines established for the preceding three years (FY 2011, FY 2012 and FY 2013). These pay lines are shown below. NIA will pay noncompeting awards at their FY2012 flat level (or FY 2013 flat level for competing awards made in FY 2013).

Funding Lines for CSR-Reviewed Applications
Requested Direct Costs
<500k
500k or greater
All applications except N.I. or E.S.I. R01s
11%
8%
N.I. R01 (not E.S.I.)
14%
11%
E.S.I. R01
16%
13%

N.I. is New investigator (no prior R01 or R01-equivalent award)
E.S.I. is Early-Stage Investigator (No prior R01 and within 10 years of finishing research training)

NIA-Reviewed Applications

For program projects (P01) and other NIA-reviewed research grant applications (some R01, R34, U01, and U19 applications) the pay line is a priority score of 13. (This is not a percentile rank.)

NIA will provide a later update concerning additional appropriations received in FY2014.

FY 2014 Funding Policy: Additional Appropriation

As described above the overall NIH appropriation was increased to $30.15 billion (a 3.4% increase) in fiscal year 2014. NIA’s budget was increased by 12.5% because Congress provided approximately $100 million in additional funding , specifying in the Conference Report accompanying the 2014 Consolidated Appropriations Act that: “recognizing that Alzheimer's disease poses a unique and serious threat to the Nation's long-term health and economic stability, the Committee expects that a significant portion of the recommended increase for NIA should be directed to research on Alzheimer's……The Committee encourages NIA to continue addressing the research goals set forth in the National Plan to Address Alzheimer's Disease, as well as the recommendations from the Alzheimer's Disease Research Summit 2012.”

Consistent with this language, NIA plans to use these additional funds to support Alzheimer’s research in areas of strategic priority. Specifically, in FY2014, NIA will fund additional awards to applications received from Funding Opportunity Announcements issued in FY2013 (the President’s Alzheimer’s initiative) and issued in FY 2014.

These additional appropriated funds are added to our base (unlike the one-time funds added by the NIH Director in FY 2012 and FY 2013). So our budget next year is estimated from this increased base. NIA is distributing these funds among single-year and multi-year projects to maintain a stream of new competing dollars to support high quality, peer-reviewed research on aging and Alzheimer’s Disease in later years.